HEADER SIGNALING PROTEIN 22-MAR-22 7ZAW TITLE GPC3-UNC5D OCTAMER STRUCTURE AND ROLE IN CELL MIGRATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYPICAN-3; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: GTR2-2,INTESTINAL PROTEIN OCI-5,MXR7; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GPC3, OCI5; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: HEK293S GNTI-; SOURCE 10 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-3022 KEYWDS GLYCOPROTEIN, MIGRATION, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR O.AKKERMANS,C.DELLOYE-BOURGEOIS,C.PEREGRINA,M.CARRASQUERO,M.KOKOLAKI, AUTHOR 2 M.BERBEIRA-SANTANA,M.CHAVENT,F.REYNAUD,R.RITU,J.AGIRRE,M.AKSU, AUTHOR 3 E.WHITE,E.LOWE,D.BEN AMAR,S.ZABALLA,J.HUO,I.PAKOS,P.MCCUBBIN, AUTHOR 4 D.COMOLETTI,R.OWENS,C.ROBINSON,V.CASTELLANI,D.DEL TORO,E.SEIRADAKE REVDAT 2 31-JAN-24 7ZAW 1 REMARK REVDAT 1 02-NOV-22 7ZAW 0 JRNL AUTH O.AKKERMANS,C.DELLOYE-BOURGEOIS,C.PEREGRINA, JRNL AUTH 2 M.CARRASQUERO-ORDAZ,M.KOKOLAKI,M.BERBEIRA-SANTANA,M.CHAVENT, JRNL AUTH 3 F.REYNAUD,R.RAJ,J.AGIRRE,M.AKSU,E.S.WHITE,E.LOWE,D.BEN AMAR, JRNL AUTH 4 S.ZABALLA,J.HUO,I.PAKOS,P.T.N.MCCUBBIN,D.COMOLETTI, JRNL AUTH 5 R.J.OWENS,C.V.ROBINSON,V.CASTELLANI,D.DEL TORO,E.SEIRADAKE JRNL TITL GPC3-UNC5 RECEPTOR COMPLEX STRUCTURE AND ROLE IN CELL JRNL TITL 2 MIGRATION. JRNL REF CELL V. 185 3931 2022 JRNL REFN ISSN 1097-4172 JRNL PMID 36240740 JRNL DOI 10.1016/J.CELL.2022.09.025 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.V.AFONINE REMARK 1 TITL TOWARDS AUTOMATED CRYSTALLOGRAPHIC STRUCTURE REFINEMENT WITH REMARK 1 TITL 2 PHENIX.REFINE. REMARK 1 REF ACTA CRYSTALLOGR., SECT. D: V. 68 352 2012 REMARK 1 REF 2 BIOL. CRYSTALLOGR. REMARK 1 REFN ISSN 0907-4449 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.LIEBSCHNER,P.V.AFONINE,M.L.BAKER,G.BUNKOCZI,V.B.CHEN, REMARK 1 AUTH 2 T.I.CROLL,B.HINTZE,L.W.HUNG,S.JAIN,A.J.MCCOY,N.W.MORIARTY, REMARK 1 AUTH 3 R.D.OEFFNER,B.K.POON,M.G.PRISANT,R.J.READ,J.S.RICHARDSON, REMARK 1 AUTH 4 D.C.RICHARDSON,M.D.SAMMITO,O.V.SOBOLEV,D.H.STOCKWELL, REMARK 1 AUTH 5 T.C.TERWILLIGER,A.G.URZHUMTSEV,L.L.VIDEAU,C.J.WILLIAMS, REMARK 1 AUTH 6 P.D.ADAMS REMARK 1 TITL MACROMOLECULAR STRUCTURE DETERMINATION USING X-RAYS, REMARK 1 TITL 2 NEUTRONS AND ELECTRONS: RECENT DEVELOPMENTS IN PHENIX. REMARK 1 REF ACTA CRYSTALLOGR D STRUCT V. 75 861 2019 REMARK 1 REF 2 BIOL REMARK 1 REFN ISSN 2059-7983 REMARK 1 PMID 31588918 REMARK 1 DOI 10.1107/S2059798319011471 REMARK 2 REMARK 2 RESOLUTION. 2.58 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.58 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.09 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 16860 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.233 REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850 REMARK 3 FREE R VALUE TEST SET COUNT : 818 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 50.0900 - 4.6800 1.00 2790 151 0.1947 0.2445 REMARK 3 2 4.6800 - 3.7200 1.00 2696 133 0.2131 0.2555 REMARK 3 3 3.7200 - 3.2500 1.00 2659 143 0.2701 0.3535 REMARK 3 4 3.2500 - 2.9500 1.00 2660 115 0.3153 0.3809 REMARK 3 5 2.9500 - 2.7400 1.00 2625 154 0.3570 0.4486 REMARK 3 6 2.7400 - 2.5800 0.99 2612 122 0.3562 0.3755 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.555 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 39.558 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 87.61 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 100.4 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 2912 REMARK 3 ANGLE : 0.679 3933 REMARK 3 CHIRALITY : 0.041 458 REMARK 3 PLANARITY : 0.005 497 REMARK 3 DIHEDRAL : 4.644 394 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -19.0789 -23.9387 11.8015 REMARK 3 T TENSOR REMARK 3 T11: 0.8183 T22: 0.8397 REMARK 3 T33: 0.5918 T12: 0.0615 REMARK 3 T13: -0.0399 T23: -0.0025 REMARK 3 L TENSOR REMARK 3 L11: 3.2620 L22: 5.2324 REMARK 3 L33: 0.7261 L12: -3.9902 REMARK 3 L13: 1.3850 L23: -1.9312 REMARK 3 S TENSOR REMARK 3 S11: -0.3338 S12: -0.3774 S13: -0.0497 REMARK 3 S21: 0.3711 S22: 0.4093 S23: 0.2156 REMARK 3 S31: -0.1868 S32: -0.1786 S33: -0.0705 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7ZAW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1292121811. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-SEP-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92010 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 S 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16895 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.580 REMARK 200 RESOLUTION RANGE LOW (A) : 86.860 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 15.50 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.58 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX 1.19.2_4158 REMARK 200 STARTING MODEL: 4YWT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% ETHYLENE GLYCOL, 10% W/V PEG 8000, REMARK 280 0.1 M TRIS/BICINE (PH 8.5) AND 0.02 M OF AMINO ACIDS (L-NA- REMARK 280 GLUTAMATE, ALANINE, GLYCINE, LYSINE-HCL, AND SERINE), VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.06200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 60.12400 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 60.12400 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 30.06200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 29 REMARK 465 THR A 30 REMARK 465 GLY A 31 REMARK 465 ASP A 32 REMARK 465 ALA A 33 REMARK 465 THR A 34 REMARK 465 SER A 40 REMARK 465 PHE A 41 REMARK 465 PHE A 42 REMARK 465 GLN A 43 REMARK 465 ARG A 44 REMARK 465 LEU A 45 REMARK 465 GLN A 46 REMARK 465 PRO A 47 REMARK 465 GLY A 48 REMARK 465 LEU A 49 REMARK 465 LYS A 50 REMARK 465 TRP A 51 REMARK 465 VAL A 52 REMARK 465 PRO A 53 REMARK 465 GLU A 54 REMARK 465 THR A 55 REMARK 465 PRO A 56 REMARK 465 VAL A 57 REMARK 465 PRO A 58 REMARK 465 LEU A 187 REMARK 465 PRO A 188 REMARK 465 ASP A 189 REMARK 465 SER A 190 REMARK 465 ALA A 191 REMARK 465 TYR A 311 REMARK 465 ARG A 312 REMARK 465 ILE A 313 REMARK 465 TYR A 314 REMARK 465 ALA A 350 REMARK 465 HIS A 351 REMARK 465 SER A 352 REMARK 465 GLN A 353 REMARK 465 GLN A 354 REMARK 465 ARG A 355 REMARK 465 GLN A 356 REMARK 465 TYR A 357 REMARK 465 ARG A 358 REMARK 465 PHE A 359 REMARK 465 ALA A 360 REMARK 465 TYR A 361 REMARK 465 TYR A 362 REMARK 465 PRO A 363 REMARK 465 GLU A 364 REMARK 465 ASP A 365 REMARK 465 LEU A 366 REMARK 465 PHE A 367 REMARK 465 ILE A 368 REMARK 465 ASP A 369 REMARK 465 LYS A 370 REMARK 465 LYS A 371 REMARK 465 VAL A 372 REMARK 465 LEU A 373 REMARK 465 LYS A 374 REMARK 465 VAL A 375 REMARK 465 ALA A 376 REMARK 465 HIS A 377 REMARK 465 VAL A 378 REMARK 465 GLU A 379 REMARK 465 HIS A 380 REMARK 465 GLU A 381 REMARK 465 GLU A 382 REMARK 465 LYS A 435 REMARK 465 ALA A 436 REMARK 465 ALA A 437 REMARK 465 ARG A 438 REMARK 465 ASN A 439 REMARK 465 GLY A 440 REMARK 465 MET A 441 REMARK 465 LYS A 442 REMARK 465 ASN A 443 REMARK 465 GLN A 444 REMARK 465 PHE A 445 REMARK 465 ASN A 446 REMARK 465 LEU A 447 REMARK 465 HIS A 448 REMARK 465 GLU A 449 REMARK 465 LEU A 450 REMARK 465 LYS A 451 REMARK 465 MET A 452 REMARK 465 LYS A 453 REMARK 465 GLY A 454 REMARK 465 PRO A 455 REMARK 465 MET A 478 REMARK 465 PRO A 479 REMARK 465 LYS A 480 REMARK 465 GLY A 481 REMARK 465 ARG A 482 REMARK 465 VAL A 483 REMARK 465 GLY A 484 REMARK 465 THR A 485 REMARK 465 LYS A 486 REMARK 465 HIS A 487 REMARK 465 HIS A 488 REMARK 465 HIS A 489 REMARK 465 HIS A 490 REMARK 465 HIS A 491 REMARK 465 HIS A 492 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 39 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 80 CG CD CE NZ REMARK 470 LEU A 192 CG CD1 CD2 REMARK 470 ASP A 193 CG OD1 OD2 REMARK 470 LYS A 221 CG CD CE NZ REMARK 470 LYS A 247 CG CD CE NZ REMARK 470 LYS A 336 CG CD CE NZ REMARK 470 LYS A 347 CG CD CE NZ REMARK 470 ARG A 389 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 431 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 36 -148.41 -89.00 REMARK 500 SER A 60 125.96 -173.46 REMARK 500 ASP A 61 40.73 -144.79 REMARK 500 VAL A 64 -61.69 -135.81 REMARK 500 GLN A 426 -19.83 -151.48 REMARK 500 SER A 433 -84.48 -95.79 REMARK 500 THR A 475 2.14 -69.09 REMARK 500 REMARK 500 REMARK: NULL DBREF 7ZAW A 32 483 UNP P51654 GPC3_HUMAN 32 483 SEQADV 7ZAW GLU A 29 UNP P51654 EXPRESSION TAG SEQADV 7ZAW THR A 30 UNP P51654 EXPRESSION TAG SEQADV 7ZAW GLY A 31 UNP P51654 EXPRESSION TAG SEQADV 7ZAW PHE A 359 UNP P51654 SER 359 CONFLICT SEQADV 7ZAW GLY A 484 UNP P51654 EXPRESSION TAG SEQADV 7ZAW THR A 485 UNP P51654 EXPRESSION TAG SEQADV 7ZAW LYS A 486 UNP P51654 EXPRESSION TAG SEQADV 7ZAW HIS A 487 UNP P51654 EXPRESSION TAG SEQADV 7ZAW HIS A 488 UNP P51654 EXPRESSION TAG SEQADV 7ZAW HIS A 489 UNP P51654 EXPRESSION TAG SEQADV 7ZAW HIS A 490 UNP P51654 EXPRESSION TAG SEQADV 7ZAW HIS A 491 UNP P51654 EXPRESSION TAG SEQADV 7ZAW HIS A 492 UNP P51654 EXPRESSION TAG SEQRES 1 A 464 GLU THR GLY ASP ALA THR CYS HIS GLN VAL ARG SER PHE SEQRES 2 A 464 PHE GLN ARG LEU GLN PRO GLY LEU LYS TRP VAL PRO GLU SEQRES 3 A 464 THR PRO VAL PRO GLY SER ASP LEU GLN VAL CYS LEU PRO SEQRES 4 A 464 LYS GLY PRO THR CYS CYS SER ARG LYS MET GLU GLU LYS SEQRES 5 A 464 TYR GLN LEU THR ALA ARG LEU ASN MET GLU GLN LEU LEU SEQRES 6 A 464 GLN SER ALA SER MET GLU LEU LYS PHE LEU ILE ILE GLN SEQRES 7 A 464 ASN ALA ALA VAL PHE GLN GLU ALA PHE GLU ILE VAL VAL SEQRES 8 A 464 ARG HIS ALA LYS ASN TYR THR ASN ALA MET PHE LYS ASN SEQRES 9 A 464 ASN TYR PRO SER LEU THR PRO GLN ALA PHE GLU PHE VAL SEQRES 10 A 464 GLY GLU PHE PHE THR ASP VAL SER LEU TYR ILE LEU GLY SEQRES 11 A 464 SER ASP ILE ASN VAL ASP ASP MET VAL ASN GLU LEU PHE SEQRES 12 A 464 ASP SER LEU PHE PRO VAL ILE TYR THR GLN LEU MET ASN SEQRES 13 A 464 PRO GLY LEU PRO ASP SER ALA LEU ASP ILE ASN GLU CYS SEQRES 14 A 464 LEU ARG GLY ALA ARG ARG ASP LEU LYS VAL PHE GLY ASN SEQRES 15 A 464 PHE PRO LYS LEU ILE MET THR GLN VAL SER LYS SER LEU SEQRES 16 A 464 GLN VAL THR ARG ILE PHE LEU GLN ALA LEU ASN LEU GLY SEQRES 17 A 464 ILE GLU VAL ILE ASN THR THR ASP HIS LEU LYS PHE SER SEQRES 18 A 464 LYS ASP CYS GLY ARG MET LEU THR ARG MET TRP TYR CYS SEQRES 19 A 464 SER TYR CYS GLN GLY LEU MET MET VAL LYS PRO CYS GLY SEQRES 20 A 464 GLY TYR CYS ASN VAL VAL MET GLN GLY CYS MET ALA GLY SEQRES 21 A 464 VAL VAL GLU ILE ASP LYS TYR TRP ARG GLU TYR ILE LEU SEQRES 22 A 464 SER LEU GLU GLU LEU VAL ASN GLY MET TYR ARG ILE TYR SEQRES 23 A 464 ASP MET GLU ASN VAL LEU LEU GLY LEU PHE SER THR ILE SEQRES 24 A 464 HIS ASP SER ILE GLN TYR VAL GLN LYS ASN ALA GLY LYS SEQRES 25 A 464 LEU THR THR THR ILE GLY LYS LEU CYS ALA HIS SER GLN SEQRES 26 A 464 GLN ARG GLN TYR ARG PHE ALA TYR TYR PRO GLU ASP LEU SEQRES 27 A 464 PHE ILE ASP LYS LYS VAL LEU LYS VAL ALA HIS VAL GLU SEQRES 28 A 464 HIS GLU GLU THR LEU SER SER ARG ARG ARG GLU LEU ILE SEQRES 29 A 464 GLN LYS LEU LYS SER PHE ILE SER PHE TYR SER ALA LEU SEQRES 30 A 464 PRO GLY TYR ILE CYS SER HIS SER PRO VAL ALA GLU ASN SEQRES 31 A 464 ASP THR LEU CYS TRP ASN GLY GLN GLU LEU VAL GLU ARG SEQRES 32 A 464 TYR SER GLN LYS ALA ALA ARG ASN GLY MET LYS ASN GLN SEQRES 33 A 464 PHE ASN LEU HIS GLU LEU LYS MET LYS GLY PRO GLU PRO SEQRES 34 A 464 VAL VAL SER GLN ILE ILE ASP LYS LEU LYS HIS ILE ASN SEQRES 35 A 464 GLN LEU LEU ARG THR MET SER MET PRO LYS GLY ARG VAL SEQRES 36 A 464 GLY THR LYS HIS HIS HIS HIS HIS HIS HET NAG A 501 14 HET NAG A 502 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 2(C8 H15 N O6) HELIX 1 AA1 SER A 74 TYR A 134 1 61 HELIX 2 AA2 PRO A 135 THR A 138 5 4 HELIX 3 AA3 PRO A 139 LEU A 157 1 19 HELIX 4 AA4 ASN A 162 LEU A 182 1 21 HELIX 5 AA5 ILE A 194 LEU A 205 1 12 HELIX 6 AA6 ASN A 210 ASP A 244 1 35 HELIX 7 AA7 SER A 249 TYR A 261 1 13 HELIX 8 AA8 TYR A 261 GLN A 266 1 6 HELIX 9 AA9 CYS A 274 MET A 286 1 13 HELIX 10 AB1 MET A 286 GLU A 291 1 6 HELIX 11 AB2 GLU A 291 MET A 310 1 20 HELIX 12 AB3 MET A 316 GLY A 322 1 7 HELIX 13 AB4 GLY A 322 LYS A 336 1 15 HELIX 14 AB5 ASN A 337 CYS A 349 1 13 HELIX 15 AB6 LEU A 384 SER A 397 1 14 HELIX 16 AB7 ALA A 404 HIS A 412 1 9 HELIX 17 AB8 PRO A 457 THR A 475 1 19 SHEET 1 AA1 2 THR A 420 TRP A 423 0 SHEET 2 AA1 2 LEU A 428 ARG A 431 -1 O VAL A 429 N CYS A 422 SSBOND 1 CYS A 35 CYS A 72 1555 1555 2.03 SSBOND 2 CYS A 65 CYS A 262 1555 1555 2.03 SSBOND 3 CYS A 73 CYS A 265 1555 1555 2.03 SSBOND 4 CYS A 197 CYS A 349 1555 1555 2.04 SSBOND 5 CYS A 252 CYS A 285 1555 1555 2.03 SSBOND 6 CYS A 274 CYS A 422 1555 1555 2.03 SSBOND 7 CYS A 278 CYS A 410 1555 1555 2.03 LINK ND2 ASN A 124 C1 NAG A 502 1555 1555 1.44 LINK ND2 ASN A 241 C1 NAG A 501 1555 1555 1.43 CISPEP 1 THR A 138 PRO A 139 0 4.68 CRYST1 100.190 100.190 90.186 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009981 0.005763 0.000000 0.00000 SCALE2 0.000000 0.011525 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011088 0.00000